[
  {
    "ts": null,
    "headline": "MAIA Biotechnology Announces First Patient Dosed in Expansion of Phase 2 Trial for Ateganosine in Advanced Non-Small Cell Lung Cancer",
    "summary": "CHICAGO, July 09, 2025--MAIA Biotechnology Announces First Patient Dosed in Expansion of Phase 2 Trial for Ateganosine in Advanced Non-Small Cell Lung Cancer",
    "url": "https://finnhub.io/api/news?id=708cbfc47ea31ee06c59fee8b1137905e1137f526ccb364953d1fd88fe97290b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752066900,
      "headline": "MAIA Biotechnology Announces First Patient Dosed in Expansion of Phase 2 Trial for Ateganosine in Advanced Non-Small Cell Lung Cancer",
      "id": 135834557,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "CHICAGO, July 09, 2025--MAIA Biotechnology Announces First Patient Dosed in Expansion of Phase 2 Trial for Ateganosine in Advanced Non-Small Cell Lung Cancer",
      "url": "https://finnhub.io/api/news?id=708cbfc47ea31ee06c59fee8b1137905e1137f526ccb364953d1fd88fe97290b"
    }
  }
]